Roundtable Joins Diverse Coalition to Voice Concern Over Proposed USMCA Trade Deal

“We are writing jointly to express our serious concern that the recently renegotiated version of the North American Free Trade Agreement (NAFTA) – now proposed to be called the U.S.-Mexico-Canada Free Trade Agreement (USMCA) – will exacerbate the problem of high prescription drug prices in the United States.”

USMCA Group Letter to Congressional Leadership

USMCA Group Letter to HHS Secretary

USMCA Group Letter to U.S. Trade Representative

USMCA Group Press Release